OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Rheumatology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Polymyalgia rheumatica and giant cell arteritis: diagnosis and management	130
Current approach to muscle imaging in myositis	66
Editorial introduction	55
Urticarial vasculitis	50
Current views on lupus in children	44
Update on antineutrophil cytoplasmic autoantibody vasculitis in children	38
Giant cell arteritis: update on pathogenesis and clinical implications	37
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence	36
Axial spondyloarthritis guidelines – aiming for maximum impact	34
Osteoporosis epidemiology using international cohorts	32
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burden	32
Editorial introductions	28
Optimizing reproductive health management in lupus and Sjogren's syndrome	27
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials	26
Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice	26
The gut microbiota in spondyloarthritis: an update	25
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus	25
Rheumatoid arthritis – the challenge of heterogeneity	25
Editorial introductions	24
Ribosome dysfunction in osteoarthritis	23
Updates on translational and clinical research in systemic sclerosis	22
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation	22
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis	20
Update on gout management: what is old and what is new	19
Management of cutaneous manifestations of systemic sclerosis: current approaches and emerging therapies	19

Insights into the pathogenic role of neutrophils in systemic lupus erythematosus	18
Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research	18
Editorial introduction	18
The role of neutrophil extracellular traps in inflammatory rheumatic diseases	18
Editorial introductions	18
Health inequities in the rheumatic diseases of childhood	17
Epidemiology of myositis	17
Defining and managing flares in axial spondyloarthritis	17
Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets	17
Animal models of vasculitis	16
Raynaud's phenomenon and digital ulcers: advances in evaluation and management	16
Editorial introductions	16
Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment	15
Gout and the COVID-19 pandemic	14
Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases	14
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis	14
Editorial introductions	13
Editorial introductions	13
Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0	13
New developments related to lung complications in pediatric rheumatic disease	13
Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?	13
Insights into origins and specificities of autoantibodies in systemic sclerosis	12
Biomarker discovery in psoriatic disease	12
Diagnosis and management of primary heart involvement in systemic sclerosis	12
Insights into the molecular landscape of osteoarthritis in human tissues	12
Investigating gout flares: beyond a definition	11
Management of postinfectious inflammatory arthritis	11
Editorial introduction	11
AI am the future: artificial intelligence in pediatric rheumatology	11
Vasculitis and the NLRP3 inflammasome	11
Polymyositis: does it really exist as a distinct clinical subset?	11
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications	10
The association of Behçet's syndrome with HLA-B51 as understood in 2021	10
Exploring challenges in the management and treatment of inclusion body myositis	10
Emerging biologic therapies for systemic lupus erythematosus	10
Epidemiology of osteoarthritis: literature update 2022–2023	10
Heart involvement in systemic sclerosis: emerging concepts	10
The contribution of endothelial cells to tissue fibrosis	9
Update on streptococcal-associated rheumatic disease	9
Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI	9
Gastrointestinal disease in systemic sclerosis: the neglected organ system?	9
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies	9
Current management of giant cell arteritis and its complications	9